Zobrazeno 1 - 10
of 10
pro vyhledávání: '"M. I. A. Madeira"'
Autor:
A. F O Costa, L. O Marani, I. A Lopes, L. S Binelli, P. S Scheucher, J. L S Schiavinato, M. I. A Madeira, K. B B Pagnano, B. K Duarte, A. B. F Glória, E. M Rego, F. Traina, R. Welner, L. L Figueiredo-Pontes
Publikováno v:
HemaSphere, Vol 6, Pp 296-297 (2022)
Externí odkaz:
https://doaj.org/article/0f4eee12b0154c18bb3ca0cb7d569770
Autor:
L. O Marani, A. Costa, F. B Silva, M. I. A Madeira, P. S Scheucher, J. L S Schiavinato, A. S. G Lima, K. B B Pagnano, B. K Duarte, S. Freeman, E. M Rego, F. Traina, L. L Figueiredo-Pontes
Publikováno v:
HemaSphere, Vol 6, Pp 1694-1695 (2022)
Externí odkaz:
https://doaj.org/article/7165a4fb48984a1f9b28d47bb5554654
Autor:
R.M.S. Soares, Llf Pontes, RS Melo, M. I. A. Madeira, FA Silva, A.H.A. Resende, P.C.C. Bariani, LS Oliveira, Acon Luz, PL Filgueiras
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S159-(2021)
Introdução: As leucemias agudas de fenótipo misto representam um grupo heterogêneo de leucemias raras nas quais não é possível atribuir uma única linhagem de origem, representando até 3% dos casos de leucemia aguda. Segundo a classificação
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::201f5c1f0cc500ee54d1329b558f180a
http://www.sciencedirect.com/science/article/pii/S253113792100417X
http://www.sciencedirect.com/science/article/pii/S253113792100417X
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S519-S520 (2021)
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy
Introducao O beneficio do uso precoce de plasma convalescente com altos titulos de anticorpos neutralizantes contra o Sars-Cov-2 vem sendo descrito. E necessario esclarecer a influencia de fatores demograficos e tipagem ABO na formacao destes anticor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df1a38a1e72cb70b4f41e6b427f65eb7
http://www.sciencedirect.com/science/article/pii/S2531137921010440
http://www.sciencedirect.com/science/article/pii/S2531137921010440
Autor:
A. S. G. Lima, Fábia Barbosa da Silva, B.K. Duarte, Lorena Lobo de Figueiredo-Pontes, JL Schiavinato, Priscila Santos Scheucher, A. Costa, M. I. A. Madeira, E.M. Rego, K.B.B. Pagnano, LO Marani, S Freeman, Fabiola Traina
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S149-S150 (2021)
Background: Diagnosis and treatment of acute myeloid leukemia (AML) remains difficult to this day, cure rates remain low and measurable residual disease (MRD) assessment is still challenging. Early detection of residual leukemic cells is essential to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc4ddb108d5d278167731407f01b4132
https://doi.org/10.1016/j.htct.2021.10.254
https://doi.org/10.1016/j.htct.2021.10.254
Autor:
P.M.M. Garibaldi, Ncr Cunha, R.M.S. Soares, FA Silva, LV Cota, Acon Luz, LB Lanza, M. I. A. Madeira, RL Pacca, RS Melo
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S211-S212 (2021)
Introducao O Bortezomibe (Velcade®) e um inibidor do proteassoma, especificamente do proteassoma 26S, cuja ligacao irreversivel leva a ativacao de cascatas de sinalizacao que culminam com a parada do ciclo celular e apoptose. Ele foi aprovado e incl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d39dc20d50fc2d7b838f818b5aaafea
https://doi.org/10.1016/j.htct.2021.10.358
https://doi.org/10.1016/j.htct.2021.10.358
Autor:
M. I. A. Madeira, C.D. Donadel, LS Oliveira, T.A.P. Gonçalves, D.C. Stocco, P.M.M. Garibaldi, V. Tomazini, J.P.L. Silva, C.M.L.B. Monteiro, P.O.C. Terra
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 277-(2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f11118684f6a75cb1ee87f851606680c
http://www.sciencedirect.com/science/article/pii/S2531137920307483
http://www.sciencedirect.com/science/article/pii/S2531137920307483
Autor:
C.M.L.B. Monteiro, P.M.M. Garibaldi, M. I. A. Madeira, P.O.C. Terra, A.H.A. Resende, V. Tomazini, Luiz Fernando Bazzo Catto, J.P.L. Silva, D.C. Stocco, C.D. Donadel
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 264-(2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3254cbd5319e3823db7094cd5d550e71
http://www.sciencedirect.com/science/article/pii/S2531137920307276
http://www.sciencedirect.com/science/article/pii/S2531137920307276
Autor:
M. Higashi, B.K. Duarte, M. I. A. Madeira, G.L. Jacovelli, Priscila Santos Scheucher, LO Marani, A.B.F. Gloria, Fábia Barbosa da Silva, E. Fagundes, J.V.P. Feliciano, Lorena Lobo de Figueiredo-Pontes, K.B.B. Pagnano, A. S. G. Lima, E.C. Nunes, F. Kerbauy, E.M. Rego, A.F.O. Costa, Fabiola Traina
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 153-154 (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5bcead1290948f6b9cfa3b1b1799ec7
http://www.sciencedirect.com/science/article/pii/S2531137920305459
http://www.sciencedirect.com/science/article/pii/S2531137920305459
Autor:
RS Melo, R.M.S. Soares, PL Filgueiras, T.E. Gonçalves, P.O.C. Terra, P.C.C. Bariani, M. I. A. Madeira, A.H.A. Resende, LS Oliveira, P.M.M. Garibaldi
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss, Pp 249-(2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7609277be366ca8f370e3d8d6882a0ea
https://doi.org/10.1016/j.htct.2020.10.417
https://doi.org/10.1016/j.htct.2020.10.417